CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Rize Oncology Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Rize Oncology Inc
c/o Pushor Mitchell LLP
301-1665 Ellis Street
Phone: (250) 869-1195p:250 869-1195 KELOWNA, BC  V1Y 2B3  Canada Ticker: RIZERIZE
Business Summary
Rize Oncology Inc., formerly GeneTether Therapeutics Inc., is a pharmaceutical company engaged in developing oncology therapies. The Company is focused on advancing treatments for soft tissue sarcoma. It is developing STS-201 for the treatment of soft tissue sarcoma. STS-201 is a small-molecule drug candidate that has exhibited significant utility in soft tissue sarcoma, as well as other types of cancers and certain proliferative diseases.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board DarenGraham 50 4/1/2021 1/1/2021
Chief Executive Officer, Director RolandBoivin 56 10/1/2021 10/1/2021
Co-Founder, Executive Director William J.Garner 57 4/1/2018 4/1/2018
3 additional Officers and Directors records available in full report.

Business Names
Business Name
GTTX
RIZE

General Information
Outstanding Shares: 75,744,674 (As of 1/10/2025)
Stock Exchange: CNQ


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, January 28, 2025